Novadaq Technologies has signed a co-marketing agreement with medical device firm Arthrex for Pinpoint flourscence imaging and 4K Synergy systems.

The deal enables both firms to combine their expertise and devices to provide world-class endoscopic system for a wide variety of surgical specialties, including orthopaedic, general, colorectal and gynecological surgeries.

Novadaq’s plug and play Pinpoint is said to facilitate the seamless integration of its SPY imaging technology into Arthrex’s Synergy system, combining the clinically relevant fluorescence imaging experience with the 4K white light endoscopic system.

Novadaq Technologies senior vice-president and general president Dr Rick Mangat said: "Arthrex is a word-class medical device company committed to innovation, medical education and patient care.

"We are excited to collaborate with Arthrex through this innovative co-marketing structure to bring the benefits of Novadaq’s fluorescence imaging to their customer base and expand adoption of Novadaq’s technology into additional markets."

The firms will continue to market their own standalone systems, in addition to the combined systems, providing more options for end-users.

The deal will allow Arthrex to include the Pinpoint upgrade kit in all new Synergy system purchases, as well as upgrade their existing installed base.

Novadaq will continue to market Pinpoint as part of its fluorescence imaging ecosystem, and will provide the disposable kits required to carry out SPY imaging procedures directly to those Arthrex customers that have purchased Pinpoint upgrade kits.